Our Firm
Strategies
Values
Portfolio
News
Investor Portal

Contact

100 North Main Street
Suite 301
Alpharetta, GA 30009

One Penn Plaza
Suite 1620
New York, NY 10119

contact@avego.com
646-844-0030

Our Firm
Strategies
Values
Portfolio
News
Investor Portal

Sentynl Therapeutics

Posted on July 13, 2021 by James Flexner -

Commercial-stage specialty pharmaceutical company.

Acquired by Zydus in 2017

Search for:

Recent Posts

Alveus Therapeutics Launches with $160 Million Series A Financing
EpiBiologics Closes $107M Series B
myTomorrows Raises $29 Million
MapLight Therapeutics Announces $372.5 Million Series D Financing
CellCentric Secures $120 Million Investment
PBS Biotech Expands Leadership Team and Secures $17 Million

Recent Comments

Links

Our Firm
Avego Healthcare Capital
Avego BioScience Capital
Velan Capital

Contact

100 North Main Street, Suite 301
Alpharetta, GA 30009

One Penn Plaza, Suite 1620
New York, NY 10119

contact@avego.com
646-844-0030

Legal

Terms of Use

© 2026 Avego.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptTerms of Use